Question to the Department of Health and Social Care:

To ask Her Majesty's Government how the NHS in England is monitoring the health outcomes of patients who no longer fit the new eligibility criteria for immunoglobulin use.

Clinicians are responsible for the ongoing monitoring and assessment of the health of their patients, using processes such as annual reviews and outpatient face-to-face or virtual appointments. Sub-regional immunoglobulin assessment panels provide oversight and scrutiny for all patients receiving immunoglobulin therapy.